bioAffinity Technologies, Inc.BIAFEarnings & Financial Report
Nasdaq · Health Care · Services-Commercial Physical & Biological Research
bioAffinity Technologies, Inc. is a clinical-stage biotechnology firm focused on developing non-invasive in vitro diagnostic tests for early detection of cancer and respiratory diseases. It serves global healthcare markets, with a core mission to deliver accessible, high-accuracy diagnostic solutions that improve patient outcomes and reduce overall healthcare system costs.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Roby | 6.44% | 603.1K | — | 2023-10-10 |